Summaries for patients. Risk for heart attacks with different NSAIDs.

Suppr

超能文献

出版信息

Ann Intern Med. 2005 Apr 5;142(7):I45. doi: 10.7326/0003-4819-142-7-200504050-00001.

DOI:10.7326/0003-4819-142-7-200504050-00001

PMID:15809454

Abstract

摘要

相似文献

Summaries for patients. Risk for heart attacks with different NSAIDs.

Ann Intern Med. 2005 Apr 5;142(7):I45. doi: 10.7326/0003-4819-142-7-200504050-00001.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.

Ann Intern Med. 2005 Apr 5;142(7):481-9. doi: 10.7326/0003-4819-142-7-200504050-00113.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):617; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00022.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):616-7; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00021.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):615-6; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00020.

Cox-2 inhibitors and cardiovascular risk: the data are inconclusive, and these drugs are needed.

Cleve Clin J Med. 2001 Nov;68(11):961-2. doi: 10.3949/ccjm.68.11.961.

The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association.

Circulation. 2005 Apr 5;111(13):1713-6. doi: 10.1161/01.CIR.0000160005.90598.41. Epub 2005 Mar 21.

COX 2 inhibitors may increase risk of heart attack.

BMJ. 2001 Sep 1;323(7311):471.

Efficacy and safety of aspirin in the long-term management of atherothrombosis.

Haematologica. 2002 Jan;87(1):6-8.

The coxibs, selective inhibitors of cyclooxygenase-2.

N Engl J Med. 2001 Dec 6;345(23):1709.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Summaries for patients. Risk for heart attacks with different NSAIDs.

Ann Intern Med. 2005 Apr 5;142(7):I45. doi: 10.7326/0003-4819-142-7-200504050-00001.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.

Ann Intern Med. 2005 Apr 5;142(7):481-9. doi: 10.7326/0003-4819-142-7-200504050-00113.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):617; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00022.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):616-7; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00021.

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ann Intern Med. 2005 Oct 18;143(8):615-6; author reply 617-8. doi: 10.7326/0003-4819-143-8-200510180-00020.

Cox-2 inhibitors and cardiovascular risk: the data are inconclusive, and these drugs are needed.

Cleve Clin J Med. 2001 Nov;68(11):961-2. doi: 10.3949/ccjm.68.11.961.

The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association.

Circulation. 2005 Apr 5;111(13):1713-6. doi: 10.1161/01.CIR.0000160005.90598.41. Epub 2005 Mar 21.

COX 2 inhibitors may increase risk of heart attack.

BMJ. 2001 Sep 1;323(7311):471.

Efficacy and safety of aspirin in the long-term management of atherothrombosis.

Haematologica. 2002 Jan;87(1):6-8.

The coxibs, selective inhibitors of cyclooxygenase-2.

N Engl J Med. 2001 Dec 6;345(23):1709.